Today the National Association of Medicaid Directors sent the attached letter to the leaders of the Senate Finance and HELP and House Energy & Commerce and Ways & Means committees regarding the current situation with break through prescription drug treatments. The letter addresses the challenges presented by new hepatitis C treatments. It focuses on issues […]

Continue reading

In this letter, the third in a series of recommendations submitted to the Centers for Medicare and Medicaid Services (CMCS), NAMD offers suggestions on ways to ensure robust consumer protections in Medicaid managed care programs. The letter provides recommendations in four main areas: network adequacy, enrollment practices, managed long term services and supports (MLTSS), and […]

Continue reading

NAMD responded to a request for information to inform potential future models to be tested under the Center for Medicare and Medicaid Innovation’s (CMMI) demonstration authority. NAMD lays out six principles to make any model relevant to and feasible for administering in the Medicaid program. Read the full letter here.

Continue reading

In this letter, NAMD offers initial recommendations on program integrity to the Centers for Medicare and CHIP Services (CMCS) and the Center for Program Integrity (CPI) to inform these agencies’ ongoing work to modernize the Medicaid managed care regulations. These recommendations focus on provider enrollment, encounter and claims data, compliance and staffing, and benefit alignment. […]

Continue reading

NAMD submitted a letter to Senate Finance Committee Chairman Ron Wyden and Committee Member Charles Grassley which offer recommendations to better streamline the use of health care data to accelerate high value reforms in the health care system. The letter responds to the Senators’ June 12 open letter to stakeholders. Read the full letter here.

Continue reading

NAMD and the National Association of State Mental Health Program Directors (NASMHPD) submitted joint comments to the Substance Abuse and Mental Health Services Administration (SAMHSA) on regulations governing the confidentiality of substance use disorder health information (42 CFR Part 2). Among other recommendations, the letter urges SAMHSA to align the privacy requirements governing alcohol and […]

Continue reading